Severe Asthma ToolkitSevere Asthma Toolkit
HomeAboutSpecific PopulationsRegistriesContributorsContact
Twitter
  • What is Severe Asthma?
    • Overview
    • Definition
    • Prevalence & Burden
    • Pathophysiology
    • Symptoms
    • Severe Asthma Attacks / Exacerbations / Flare-ups
    • Asthma Phenotypes
  • Diagnosis & Assessment
    • Overview
    • Diagnosis Overview
    • Assessment Overview
    • Lung Function Assessments
    • Questionnaires
    • Allergy Assessments
    • Phenotyping
    • Bronchoscopy
    • Imaging
    • Occupational Asthma
  • Management
    • Overview
    • Asthma Education
      • About Severe Asthma
      • Asthma Pathophysiology
      • Medications Education
      • Self-Monitoring
      • Triggers
      • Review
    • Written Action Plans
    • Adherence
    • Inhaler Technique
    • Physical Activity & Exercise
    • Interdisciplinary Approach & Multidimensional Assessment
    • Referral
  • Medications
    • Overview
    • Relievers
    • Preventers / Controllers
    • Add-on Therapies
    • Monoclonal Antibodies
      • Travelling with Monoclonal Antibodies
    • Bronchial Thermoplasty
  • Co-Morbidities
    • Overview
    • Pulmonary & Upper Airways
      • Allergic & Non-Allergic Rhinitis
      • Chronic Rhinosinusitis
      • Dysfunctional Breathing
      • Vocal Cord Dysfunction
      • Chronic Obstructive Pulmonary Disease
      • Bronchiectasis
      • Obstructive Sleep Apnoea
    • Extra-Pulmonary
      • Obesity
      • Anxiety & Depression
      • Gastro-oesophageal Reflux Disease (GORD)
      • Osteoporosis
      • Cardiovascular Disease & Metabolic Disease
  • Living with Severe Asthma
    • Overview
    • Daily Symptom Burden
    • Mental & Emotional Health
    • Intimacy & Relationships
    • Self-Management Support
    • Medication Use & Costs
    • Experience of Care
    • Experience of Asthma Attacks
    • Prognosis
  • Establishing a Clinic
    • Overview
    • Set-up
    • Staffing & Multidisciplinary Team Approach
    • Facilities
    • Delivery Approach
    • Tailored Referrals
    • Evaluation
    • Opportunities for Training & Research
    • Barriers & Hurdles
  • Paediatrics
    • Overview
    • Management in Paediatrics
    • Assessment in Paediatrics
    • Alternative Diagnosis & Co-Morbidities in Paediatrics
    • Psychosocial Issues in Paediatrics
    • Medications in Paediatrics
    • Asthma in the Adolescent Population
  • Resources
    • Overview
    • Clinic Recommendations
    • Infographics
    • Asthma Assessment Resources
    • Systematic & Multidimensional Assessment Resources
      • Airway Components
      • Comorbidity Components
      • Risk Factor Components
    • Translation & Implementation
    • Case Studies
    • Presentations
    • Videos
    • Relevant Links
    • Key References

Barriers & Hurdles

Home Establishing a Clinic Barriers & Hurdles
Barriers

Barriers & Hurdles when Establishing a Severe Asthma Clinic

Several barriers and hurdles need to be considered when establishing a severe asthma clinic.

These can include people resources, such as the clinician’s time and availability, access to suitably qualified specialist health care professionals, appropriate administration support and access to multidisciplinary team members (e.g. speech pathologists, dietitians, physiotherapists, psychologists, pharmacists etc).

A multidimensional assessment and management approach can improve patient outcomes (Clark et al. 2017). However, this approach is not without its challenges, and requires careful coordination and communication between team members.

Physical resources can also provide a barrier to setting up a severe asthma clinic such as access to physical space, access to equipment (such as spirometry), and access to add-on therapies (such as the monoclonal antibody therapies). Add-on therapies may require additional assessments to support confirmation of patient eligibility and for monitoring of adverse events following treatment. For example, monitoring for anaphylaxis responses following monoclonal antibody treatment.

Health care system structure may add an additional layer of complexity requiring identification of referral pathways and initial referral generation after the establishment of a new clinic. Referral pathways must be coordinated and clearly communicated. In addition, eligibility for claiming from the Medicare Benefits Schedule and/or Activity Based Funding will need to be determined before the clinic commences.

Patient related factors may also provide a barrier to the successful implementation of the severe asthma clinic. Patient factors can include poor uptake by patients due to an inconvenient location, transportation issues, travel required from rural settings, waiting lists, costs (including direct medication costs and indirect costs of time off work and clinic attendance), and/or clinic hours/flexibility.

Which barriers and hurdles are relevant and how they can be overcome will be dependent on the local context and environment. Barriers may be particularly relevant for add-on monoclonal antibody treatment, which requires repeated patient clinic attendance on a biweekly or monthly basis.

Previous
Paediatrics

Last Updated on February 13, 2019

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

More results...

  • Overview
  • Set-up
  • Staffing & Multidisciplinary Team Approach
  • Facilities
  • Delivery Approach
  • Tailored Referrals
  • Evaluation
  • Opportunities for Training & Research
  • Barriers & Hurdles

We want to know who accesses the Severe Asthma Toolkit and how it is used. Please complete our survey.

Responses will inform the continued development of the Severe Asthma Toolkit and future translation and implementation activities. Any feedback you provide will be greatly appreciated.

Complete Survey

  • Website Terms of Use
  • Website Survey
© Copyright 2018    CRICOS Provider Number 00109J    The University of Newcastle, Australia